Research graph
References from Trends and Disparities in Mortality Involving Co-Documented Sepsis and Obesity in the United States, 1999–2024: A Serial Cross- Sectional Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
2026 · External reference
Obesity and risk of sepsis: a population-based cohort study
10.1002/oby.20468 · 2013 · External reference
Adult obesity and risk of severe infections: a multicohort study with global burden estimates
10.1016/s0140-6736(25)02474-2 · 2026 · External reference
Emerging mechanisms of obesity-associated immune dysfunction
10.1038/s41574-023-00932-2 · 2024 · External reference
Obesity paradox in sepsis: a systematic review and meta-analysis of short- and long-term mortality risks. Med Intensiva (Engl Ed)
10.1016/j.medine.2026.502562 · 2026 · External reference
Does obesity protect against death in sepsis? A retrospective cohort study of 55,038 adult patients
10.1097/ccm.0000000000003692 · 2019 · External reference
Varying estimates of sepsis mortality using death certificates and administrative codes—United States, 1999–2014
10.15585/mmwr.mm6513a2 · 2016 · External reference
National Vital Statistics System: Mortality Multiple Cause-of-Death File
2025 · External reference
Trends in mortality from cancer and sepsis in the United States, 1999 to 2023: an analysis of CDC WONDER data
10.1097/md.0000000000049100 · 2026 · External reference
Trends and disparities in mortality due to diabetes mellitus and sepsis in the US adults: 1999–2023
10.1002/edm2.70082 · 2025 · External reference
Sepsis and acute kidney injury-related mortality in the U.S.: national trends and disparities (1999–2023)
10.1097/md.0000000000049495 · 2026 · External reference
Nationwide trends and disparities in deaths following cardiogenic shock and sepsis in the United States (1999–2023): insights from the CDC WONDER database
10.1186/s12872-025-05402-3 · 2025 · External reference
Is there an obesity paradox in critical illness? Epidemiologic and metabolic considerations
10.1007/s13679-020-00394-x · 2020 · External reference
Obesity paradox in critically ill patients: do patients with critical diseases benefit from obesity?
10.1159/000547813 · 2025 · External reference
The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox
10.1007/s13679-019-00360-2 · 2019 · External reference
White adipose tissue browning in critical illness: a review of the evidence, mechanisms and future perspectives
10.1111/obr.13085 · 2020 · External reference
Mitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention study
10.1186/s12913-022-08331-5 · 2022 · External reference
Multimodal quality initiatives in sepsis care: assessing impact on core measures and outcomes
10.1097/jhq.0000000000000440 · 2024 · External reference
The effect of semaglutide on mortality and COVID-19-related deaths: an analysis from the SELECT trial
10.1016/j.jacc.2024.08.007 · 2024 · External reference
